Article metrics

Download PDFPDF

POS0679 CLINICAL OUTCOMES UP TO WEEK (W) 48 IN THE ONGOING FILGOTINIB (FIL) LONG-TERM EXTENSION (LTE) TRIAL OF RHEUMATOID ARTHRITIS (RA) PATIENTS (pts) WITH INADEQUATE RESPONSE (IR) TO METHOTREXATE (MTX) INITIALLY TREATED WITH FIL OR ADALIMUMAB (ADA) DURING THE PHASE 3 PARENT STUDY (PS)
Free

 

Online download statistics by month:

Online download statistics by month: May 2022 to January 2024

AbstractFullPdf
May 20227000
Jun 2022105018
Jul 202261012
Aug 20223203
Sep 202286012
Oct 20224605
Nov 20224006
Dec 20222704
Jan 20232601
Feb 20233308
Mar 20231602
Apr 20232204
May 20231004
Jun 20231202
Jul 202320010
Aug 20231405
Sep 20233704
Oct 20231603
Nov 20232605
Dec 20232000
Jan 20241904
Total7380112